Results 51 to 60 of about 2,054,122 (239)

Combined Transcatheter Tricuspid and Pulmonary Valve Replacement. [PDF]

, 2020
For patients with combined tricuspid and pulmonary valve disease, operative intervention carries high mortality risk. Published reports of combined transcatheter tricuspid and pulmonary valve replacement have been limited to single cases.A retrospective ...
Small, Adam J, Aksoy, Olcay, Salem, Morris M, Yang, Eric H, Levi, Daniel S, Aboulhosn, Jamil A   +5 more
core   +1 more source

Repeat Mitral Transcatheter Edge‐to‐Edge Repair for Recurrent Significant Mitral Regurgitation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background There are limited data on repeat mitral transcatheter edge‐to‐edge repair for recurrent significant mitral regurgitation (MR). Methods and Results We conducted a single‐center, retrospective analysis of consecutive patients referred to a ...
Alon Shechter, Mirae Lee, Danon Kaewkes, Ofir Koren, Sabah Skaf, Tarun Chakravarty, Keita Koseki, Vivek Patel, Raj R. Makkar, Robert J. Siegel   +9 more
doaj   +1 more source

Tricuspid Regurgitation: A Review of Current Interventional Management

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Tricuspid regurgitation is a common yet clinically complex problem, traditionally managed with diuretic therapy with no observable mortality benefit. Older studies on surgical intervention observed poor outcomes; however, this clinical reasoning predates
Maxwell Ambrosino, Matthew Sangoi, Nasser Monzer, Brett Irving, Paul Fiorilli, Benjamin Khazan, Sheldon Goldberg   +6 more
doaj   +1 more source

Future Perspectives in Percutaneous Treatment of Tricuspid Regurgitation

Frontiers in Cardiovascular Medicine, 2020
Tricuspid regurgitation (TR) has a not negligible prevalence and its severity is correlated with poorer outcomes. However, surgical options are rarely offered to these patients because of their high surgical risk.
Antonio Mangieri, Matteo Pagnesi, Damiano Regazzoli, Alessandra Laricchia, Edwin Ho, Ythan Goldberg, Mei Chau, Francesco Gallo, Andrea Fisicaro, Arif Khokhar, Antonio Colombo, Francesco Giannini, Azeem Latib   +12 more
doaj   +1 more source

Emerging Transcatheter Therapies for Valvular Heart Disease: Focus on Mitral and Tricuspid Valve Procedures

Life
The emergence of percutaneous treatment options provides novel therapeutic alternatives for older and feeble patients who are at high risk for any surgical procedure.
Nikolaos Ktenopoulos, Odysseas Katsaros, Anastasios Apostolos, Maria Drakopoulou, Grigorios Tsigkas, Constantinos Tsioufis, Periklis Davlouros, Konstantinos Toutouzas, Antonios Karanasos   +8 more
doaj   +1 more source

Valve-in-Ring Transcatheter Heart Valve for Severe Tricuspid Regurgitation

JACC: Case Reports, 2019
We report the case of a man with recurrent decompensated right-sided heart failure secondary to severe tricuspid regurgitation after tricuspid annuloplasty.
Leigh A. Cummins, MBBS, Gita Mathur, BSc, MBBS, Nigel S. Jepson, MBBS, Virag V. Kushwaha, BSc, MBBS, PhD   +3 more
doaj   +1 more source

State-of-the-Art Review: Anatomical and Imaging Considerations During Transcatheter Tricuspid Valve Repair Using an Annuloplasty Approach

Frontiers in Cardiovascular Medicine, 2021
Transcatheter techniques for the treatment of tricuspid regurgitation (TR) are being more frequently used and several new devices are in development.
Nina C. Wunderlich, Melanie Landendinger, Martin Arnold, Stephan Achenbach, Martin J. Swaans, Robert J. Siegel, Siew Yen Ho   +6 more
doaj   +1 more source

Early deterioration of right ventricular strain in patients undergoing transcatheter tricuspid valve intervention

European Heart Journal, 2023
Severe tricuspid regurgitation (TR) leads to volume overload and increased wall stress causing detrimental right ventricular (RV) remodelling and dysfunction and is associated with excess mortality. Transcatheter tricuspid valve interventions (TTVI)
J. Von Stein, P. von Stein, M. Koerber, S. Baldus, R. Pfister, C. Iliadis   +5 more
semanticscholar   +1 more source

Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß, Philipp Mourikis, Fabian Nienhaus, Jafer Haschemi, Alexander Hoss, Tobias Zeus, Hanna Kowalski, Maximilian Spieker, Christian Jung, Patrick Horn, Hug Aubin, Artur Lichtenberg, Richard Truse, Malte Kelm, Amin Polzin   +14 more
wiley   +1 more source

Most Hospitalized Patients with Significant Tricuspid Regurgitation Have Advanced Disease Preventing Transcatheter Tricuspid Valve Intervention

medRxiv, 2023
Background: More than moderate tricuspid regurgitation (TR) is associated with high mortality. Surgical tricuspid valve repair and replacements are rarely performed due to high operative mortality risk, mainly attributed to late presentation.
A. D. Dumitriu Carcoana, Christopher B Scoma, S. Maletz, Jose A Malavet, Daniela R. Crousillat, F. Matar   +5 more
semanticscholar   +1 more source